Elevated eosinophil level predicted long time to next treatment in relapsed or refractory myeloma patients treated with lenalidomide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elevated eosinophil level predicted long time to next treatment in relapsed or refractory myeloma patients treated with lenalidomide

Published:2020-01-16 Issue:5 Volume:9 Page:1694-1702
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Suzuki Kazuhito¹²^ORCID,Nishiwaki Kaichi¹²^ORCID,Gunji Tadahiro¹,Katori Mitsuji¹²,Masuoka Hidekazu¹²,Yano Shingo¹

Affiliation:

1. Division of Clinical Oncology and Hematology Department of Internal Medicine The Jikei University School of Medicine Tokyo Japan

2. Division of Clinical Oncology and Hematology Department of Internal Medicine The Jikei University Kashiwa Hospital Kashiwa Chiba Japan

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2828

Reference62 articles.

1. Improved survival in multiple myeloma and the impact of novel therapies

2. International Staging System for Multiple Myeloma

3. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

4. Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

5. IMWG consensus on risk stratification in multiple myeloma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UK Stakeholder Perspectives on Surrogate Endpoints in Cancer, and the Potential for UK Real-World Datasets to Validate Their Use in Decision-Making;Cancer Management and Research;2024-07

2. Developing mRNA signatures as a novel prognostic biomarker predicting high risk multiple myeloma;Frontiers in Oncology;2023-02-23

3. N6‐methyladenosine regulators are potential prognostic biomarkers for multiple myeloma;IUBMB Life;2022-10-08

4. Solving the Conundrum of Eosinophils in Alloimmunity;Transplantation;2021-12-27

5. Lenalidomide;Reactions Weekly;2020-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3